Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding. [NA]
A clinical trial is investigating Pipelle under ultrasound guidance (PUG) to evaluate post-menopausal bleeding, and recruitment is currently…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: EC_ItaLynch: Mainstreaming the Diagnosis of Lynch Syndrome
This clinical trial evaluates a streamlined approach to diagnosing Lynch syndrome in the context of Lynch syndrome and endometrial cancer. T…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Trial status update indicates that a study using ultrasound-guided Tru-Cut biopsy for pelvic masses is recruiting, involving patients with o…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer [Phase 3]
A Phase 3 clinical trial update on the combination of Anlotinib hydrochloride capsules with TQB2450 for endometrial cancer, currently NOT_YE…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer [NA]
A clinical trial evaluating postoperative hypofractionated intensity-modulated radiotherapy for endometrial cancer is currently recruiting, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study.
A retrospective cohort study evaluating ultrasound performance in women with postmenopausal or abnormal uterine bleeding across White and Bl…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence
A recruiting clinical trial evaluating immunotolerance and immune profiling in the endometrial cancer tumor microenvironment to improve risk…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ILB2109 in combination with toripalimab in patients with advanced solid malignancies, currently recrui…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women [NA]
This ClinicalTrials.gov entry describes a prospective study evaluating endometrial cancer and endometrial hyperplasia in childbearing-age wo…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of camrelizumab and fluzoparib for TP53-mutated endometrial cancer is currently recruiti…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation
A registered clinical trial studying POLE gene mutation as a prognostic factor in endometrial cancer across early and advanced stages; recru…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: DOvEE - Diagnosing Ovarian & Endometrial Cancer Early
A clinical trial update for DOvEE (Diagnosing Ovarian & Endometrial Cancer Early) currently RECRUITING.
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer [Phase 2, Phase 3]
Navtemadlin is being studied as maintenance therapy for TP53 wild-type advanced or recurrent endometrial cancer in a Phase 2/Phase 3 trial; …
-
CLINICAL_TRIALS research · 2020-02-28Clinical Trial Update: Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. [Phase 4]
Phase 4 trial evaluating fluciclovine uptake in cervical, endometrial, and ovarian epithelial cancers.
-
CLINICAL_TRIALS research · 2019-02-12Clinical Trial Update: Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease [NA]
This clinical trial update describes a consolidation study evaluating detection rates of metastatic disease in sentinel node mapping for end…
-
CLINICAL_TRIALS research · 2019-02-01Clinical Trial Update: Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies [Phase 1]
Phase 1 clinical trial update evaluating COTI-2 as a monotherapy or in combination for multiple malignancies, sponsored by Critical Outcome …
-
CLINICAL_TRIALS research · 2019-01-25Clinical Trial Update: HE4 is a Beneficial Biomarker in Endometrial Cancer
A clinical trial update notes research on HE4 as a biomarker in endometrial cancer conducted by Ain Shams University; no outcome or trial st…
-
CLINICAL_TRIALS research · 2019-01-23Clinical Trial Update: Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
A clinical trials update describing research into healthcare decisions after Lynch syndrome genetic testing, including risk-reducing and pre…
-
CLINICAL_TRIALS research · 2018-04-12Clinical Trial Update: Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
This study investigates patient, physician, and nurse factors that influence whether patients with cervical, endometrial, or uterine cancers…
-
CLINICAL_TRIALS research · 2017-11-06Clinical Trial Update: Follow-up of Endometrial Cancer Patients [NA]
Follow-up update for a clinical trial involving endometrial cancer patients (NCT01853865) sponsored by Odense University Hospital; the trial…
-
CLINICAL_TRIALS research · 2017-08-23Clinical Trial Update: Prognostic Biomarkers in Patients With Endometrial Cancer
This clinical trial update reports on prognostic biomarkers in patients with endometrial cancer. The study sponsored by the Gynecologic Onco…
-
CLINICAL_TRIALS research · 2017-08-18Clinical Trial Update: Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells.
A completed clinical trial examining the expression levels of Progesterone Induced Blocking Factor in endometrial cancer cells.
-
CLINICAL_TRIALS research · 2017-06-22Clinical Trial Update: Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating PM01183 in combination with Olaparib for advanced solid tumors, including ovarian, endometrial, and brea…
-
CLINICAL_TRIALS research · 2017-06-12Clinical Trial Update: Adjuvant Protontherapy of Cervical and Endometrial Carcinomas [NA]
Clinical trial update on adjuvant proton therapy for cervical and endometrial cancers. The current status of the trial is unknown.
-
CLINICAL_TRIALS research · 2017-05-08Clinical Trial Update: Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer [NA]
Clinical trial update on lymphedema after surgery in patients with endometrial, cervical, or vulvar cancer; trial status is unknown.